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BACKGROUND: Persistent sensorimotor impairments after stroke can negatively impact quality of life. The hippocampus is
vulnerable to poststroke secondary degeneration and is involved in sensorimotor behavior but has not been widely studied
within the context of poststroke upper-limb sensorimotor impairment. We investigated associations between non-lesioned
hippocampal volume and upper limb sensorimotor impairment in people with chronic stroke, hypothesizing that smaller ipsilesional hippocampal volumes would be associated with greater sensorimotor impairment.
METHODS AND RESULTS: Cross-sectional T1-weighted magnetic resonance images of the brain were pooled from 357 participants
with chronic stroke from 18 research cohorts of the ENIGMA (Enhancing NeuoImaging Genetics through Meta-Analysis) Stroke
Recovery Working Group. Sensorimotor impairment was estimated from the FMA-UE (Fugl-Meyer Assessment of Upper Extremity).
Robust mixed-effects linear models were used to test associations between poststroke sensorimotor impairment and hippocampal volumes (ipsilesional and contralesional separately; Bonferroni-corrected, P<0.025), controlling for age, sex, lesion volume,
and lesioned hemisphere. In exploratory analyses, we tested for a sensorimotor impairment and sex interaction and relationships
between lesion volume, sensorimotor damage, and hippocampal volume. Greater sensorimotor impairment was significantly associated with ipsilesional (P=0.005; β=0.16) but not contralesional (P=0.96; β=0.003) hippocampal volume, independent of lesion
volume and other covariates (P=0.001; β=0.26). Women showed progressively worsening sensorimotor impairment with smaller
ipsilesional (P=0.008; β=−0.26) and contralesional (P=0.006; β=−0.27) hippocampal volumes compared with men. Hippocampal
volume was associated with lesion size (P<0.001; β=−0.21) and extent of sensorimotor damage (P=0.003; β=−0.15).
CONCLUSIONS: The present study identifies novel associations between chronic poststroke sensorimotor impairment and ipsilesional hippocampal volume that are not caused by lesion size and may be stronger in women.
Correspondence to: Sook-Lei Liew, PhD, OTR/L, University of Southern California, 2025 Zonal Ave, Los Angeles, CA 90033. Email: sliew@usc.edu
Preprint posted on BioRxiv October 28, 2021. doi: https://doi.org/10.1101/2021.10.26.465924
Supplemental Material for this article is available at https://www.ahajournals.org/doi/suppl/10.1161/JAHA.121.025109
For Sources of Funding and Disclosures, see page 12.
© 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative
Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use
is non-commercial and no modifications or adaptations are made.
JAHA is available at: www.ahajournals.org/journal/jaha

J Am Heart Assoc. 2022;11:e025109. DOI: 10.1161/JAHA.121.0251091

Zavaliangos-Petropulu et al

ENIGMA Stroke Hippocampal Volumes

Key Words: hippocampus ■ MRI ■ sensorimotor impairment ■ stroke

CLINICAL PERSPECTIVE
What Is New?

• In this study, we report a novel association
between more severe sensorimotor impairment and smaller ipsilesional hippocampal volume in patients with chronic stroke, which is
not caused by lesion size or lesion damage to
sensorimotor-specific regions, and which may
be stronger in women than in men.

What Are the Clinical Implications?

• These findings are of clinical interest because
they provide initial evidence linking the integrity
of the non-lesioned hippocampus (a key region
of the limbic system associated with cognition
and mood) to poststroke sensorimotor outcomes. This result provides support for holistic
therapeutic approaches that are applicable to
multiple domains of well-being.
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Nonstandard Abbreviations and Acronyms
ENIGMA
FMA-UE
SD

S

Enhancing NeuroImaging Genetics
through Meta-Analysis
Fugl-Meyer Assessment of Upper
Extremity
spreading depression

ensorimotor impairments are a major burden of
disease for stroke survivors.1 To help clinicians,
caregivers, and patients make informed and effective rehabilitation treatment decisions, there is a
critical need to identify biomarkers that accurately predict a patient’s potential for sensorimotor recovery.2,3
Magnetic resonance imaging (MRI) studies of regional
brain volumes suggest that secondary degeneration
of adjacent or remote regions may contribute to sensorimotor impairment and could influence poststroke
sensorimotor outcomes.4,5
The hippocampus is a brain region that is particularly vulnerable to poststroke secondary degeneration.
Both rodent6 and human7–9 stroke studies have shown
evidence of damage within the hippocampus in the
same hemisphere as an infarct (ipsilesional), but outside of the lesion itself. Using structural MRI, smaller
ipsilesional hippocampal volumes in patients with
stroke have been reported in comparison to healthy

controls,7–9 as well as smaller bilateral hippocampal
volumes at the time of stroke10 and accelerated hippocampal atrophy observed most prominently 3 months
after stroke.6,9 Studies have also reported magnetic
resonance spectroscopy evidence of contralesional
hippocampal neuronal loss8 and contralesional hippocampal atrophy measured with longitudinal MRI.9
Given that stroke-related infarctions of the hippocampus are uncommon,11 poststroke hippocampal atrophy
may be attributed to secondary degenerative mechanisms such as spreading depression (SD)6 or reduced
connectivity to lesioned structures,11 among others.
However, the extent to which lesion volume relates to
hippocampal damage remains unclear.
The hippocampus is widely known for its key role in
memory, and this has led the field of stroke recovery
research to primarily focus on the role of hippocampal damage in cognitive impairment.6–8 Although not
typically considered a primary sensorimotor region,
there is evidence that the hippocampus may also be
involved in sensorimotor behavior. The hippocampus
is densely connected to brain areas that play an important role in sensorimotor processing such as the
thalamus and basal ganglia through the spinal-limbic
pathway.12 Reports of hippocampal activity during sensorimotor behavior such as sensorimotor integration,13
sensorimotor learning,14 and motor control14 suggest
that the hippocampus plays a role in sensorimotor circuits. Sensorimotor task-related functional connectivity with the hippocampus has also been reported with
the thalamus,15 sensorimotor cortex,14 and the supplementary motor area.16 However, the relationship between hippocampal structural integrity and poststroke
upper-limb sensorimotor impairment remains unclear.
Given the potential involvement of the hippocampus
in sensorimotor circuits, hippocampal damage caused
by secondary degeneration after stroke could further weaken sensorimotor circuits, leading to greater
chronic sensorimotor impairment. Alternatively, damage to the thalamus, basal ganglia, sensorimotor cortex, or supplementary motor area, which are typically
associated with greater sensorimotor impairment, may
lead to downstream degeneration of the hippocampus
through functional or structural connections.
Dementia studies17 and healthy aging18 research
also suggest that hippocampal atrophy may differ by
sex, because hippocampal atrophy has been found to
accelerate in women after menopause. Estrogen levels
may play a mediating role in these trends19 and have
been associated with stroke severity and mortality.20
Stroke-related outcomes including disability and quality of life are generally poorer in women than men,1,21
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although conclusive sex differences have not been
reported in terms of poststroke sensorimotor impairment.22 As such, sex could moderate the relationship
between sensorimotor impairment and hippocampal
volume following a stroke. In particular, women may
have smaller hippocampal volumes and worse sensorimotor impairment, potentially leading to stronger effect sizes compared with men.
In addition, associations between lesion size and
hippocampal volume remain unclear. One study reports that larger lesion size is directly associated with
smaller hippocampal volumes,7 while other studies
report no clear relationship.6,8 Given this lack of consensus, we also investigated whether lesion size was
independently associated with hippocampal volume,
using a large sample of brain MRI scans with manually
segmented stroke lesions.
The current study is a first step towards examining
whether there is an association between the volume of
the non-lesioned poststroke hippocampus and sensorimotor impairment using a large cross-sectional data
set. In this study, we aimed to investigate the relationship between sensorimotor impairment and ipsilesional
and contralesional hippocampal volumes (separately)
in 357 participants with chronic stroke across 18 cohorts from the ENIGMA (Enhancing NeuoImaging
Genetics through Meta-
Analysis) Stroke Recovery
Working Group.23 Because of the heterogeneity of
poststroke brain reorganization across individuals,
large consortium-based multisite studies such as the
ENIGMA Stroke Recovery Working Group are important for achieving large and diverse samples that can
identify associations that may have otherwise been undetectable in a smaller single-site sample.24 In addition,
the diversity of data allows us to verify whether associations are maintained beyond a single cohort, improving the robustness and generalizability of research
findings. First, we investigated associations between
sensorimotor impairment and hippocampal volume,
controlling for lesion size and additional covariates of
age, sex, and lesioned hemisphere. The Fugl-Meyer
Assessment of Upper Extremity (FMA-UE) was used
as a measure of sensorimotor impairment of the paretic
upper limb.25 We hypothesized that greater poststroke
sensorimotor impairment would be correlated with
smaller ipsilesional but not contralesional hippocampal
volume. We hypothesized, based on the involvement
of the hippocampus in sensorimotor circuits, that the
association between ipsilesional hippocampal volume
and sensorimotor impairment would be independent
of lesion size. Second, in an exploratory analysis, we
tested to see whether sex had a moderating effect on
the relationship between sensorimotor impairment and
hippocampal volume. Because of more severe hippocampal vulnerability and poorer stroke outcome trends
in women, we hypothesized that women would have a

ENIGMA Stroke Hippocampal Volumes

stronger relationship between more severe sensorimotor impairment and smaller hippocampal volume than
men. Given the lack of consensus in the literature regarding lesion size and hippocampal volume, we independently tested associations between lesion size and
hippocampal volume, without the FMA-UE included
in the model. We hypothesized that larger lesion size
would be significantly associated with smaller ipsilesional but not contralesional hippocampal volumes.
Finally, we also tested to see whether damage to sensorimotor regions specifically was associated with ipsilesional hippocampal volume. We hypothesized that
greater damage to sensorimotor regions would be correlated with smaller ipsilesional hippocampal volumes,
independent of lesion size.

METHODS
Data Availability
To protect the privacy of research participants, individual subject data used in this study are not available
in a public repository. Participating research cohorts
vary in public data-sharing restrictions as determined
by the following: (1) ethical review board and consent
documents; (2) national and transnational sharing
laws; and (3) institutional processes that may require
signed data transfer agreements for limited, predefined
data use. However, data sharing is possible for new
and participating ENIGMA Stroke Recovery Working
Group members who agree to the consortium’s ethical standards for data use and upon the submission
of a secondary analysis plan for group review. Upon
the approval of the proposed analysis plan, access to
relevant data is provided contingent on local principal
investigator approval, data availability, and compliance
with supervening regulatory boards. Deidentified summary data as well as code used for this study can be
made available upon reasonable request to the corresponding author.

ENIGMA Stroke Recovery Data Set
A subset of cross-sectional data from the ENIGMA
Stroke Recovery Working Group database (available as of December 15, 2020) was used. Details of
the ENIGMA Stroke Recovery procedures and methods are available in Liew and colleagues.23 The data
were derived from 18 research studies (cohorts) conducted at 10 different research institutes in 6 countries (Table 1). Informed consent was obtained from all
subjects, and data were collected in compliance with
each institution’s local ethical review boards and in accordance with the Declaration of Helsinki.
ENIGMA Stroke Recovery participants with the following data were included: (1) high-resolution (1-mm
isotropic) T1-weighted brain MRI (T1w) acquired with a
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Table 1. Demographics for ENIGMA Stroke Recovery Working Group Participants Included in the Study by Cohort
Cohort

Total No. (women/men)

Median age (y)
(IQR, min–max)

Median FMA-UE
(IQR, min–max)

Median lesion size (cm3)
(IQR, min–max)

Cohort 1

39 (10/29)

61 (17, 31–80)

43 (16, 0–58)

6.1 (20.3, 0.04–120.8)

Cohort 2

12 (6/6)

69.5 (12, 39–85)

33 (27, 13–48)

28.3 (28.5, 4.2–137.4)

Cohort 3

15 (6/9)

61 (17, 33–85)

16 (13, 5–40)

21.1 (68.7, 0.6–182.2)

Cohort 4

19 (6/13)

44 (15, 30–68)

10 (11, 1–34)

35.8 (54.4, 4.5–313.5)

Cohort 5

28 (12/16)

64 (18, 44–81)

52 (33, 8–65)

1.9 (25.7, 0.1–237.7)

Cohort 6

10 (3/7)

61 (12.5, 49–72)

65 (3, 45–65)

1.4 (1.1, 0.5–9.1)

Cohort 7

14 (5/9)

58 (12, 45–69)

63 (14, 6–65)

2.0 (2.9, 0.04–6.9)

Cohort 8

11 (4/7)

56 (12, 45–74)

48 (15, 25–55)

35.8 (50.2, 0.7–103.9)

Cohort 9

11 (3/8)

59 (3, 45–68)

38 (18, 15–49)

2.6 (21.7, 0.7–53.7)

Cohort 10

8 (4/4)

58 (8, 46–73)

48 (16, 35–59)

28.4 (43.2, 0.4–59)

Cohort 11

22 (6/16)

61.5 (11, 23–75)

49 (22, 23–64)

5.6 (41.5, 0.4–201.4)

Cohort 12

13 (4/9)

57 (13, 32–80)

54 (15, 38–63)

4.8 (18.2, 0.3–98)

Cohort 13

12 (4/8)

66 (16, 31–83)

51 (26, 19–62)

4.4 (37.6, 0.2–107.5)

Cohort 14

29 (18/11)

50 (15, 25–79)

41 (13, 24–53)

12.1 (28.6, 0.1–143.6)

Cohort 15

10 (3/7)

61.5 (11, 42–76)

29 (16, 11–60)

9.1 (23.4, 3–186.1)

Cohort 16

40 (14/26)

66.5 (11, 43–93)

47 (30, 4–65)

9.2 (26.1, 0.5–111.8)

Cohort 17

36 (15/21)

70 (14, 37–80)

53 (27, 8–65)

7.6 (29.3, 0.3–188.4)

Cohort 18

28 (12/16)

64 (14, 34–85)

27 (5, 14–34)

5 (29.4, 0.7–136.9)

Total

357 (135/222)

61 (18, 23–93)

41 (28, 0–65)

7.6 (33.4, 0.04–313.5)

Total sample size (N), number of women and men, and information about age (years), Fugl-Meyer Assessment of Upper Extremity (FMA-UE), and raw lesion
size in cubic centimeters (cm3) are listed. For more information regarding cohort demographics by sex, see Tables S1 and S2. ENIGMA indicates Enhancing
NeuoImaging Genetics through Meta-Analysis; and IQR, interquartile range.
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3T MRI scanner; (2) Fugl-Meyer Assessment of Upper
Extremity score (FMA-UE; acquired on a scale from 0
to 66: 0=severe sensorimotor impairment, 66=no sensorimotor impairment); (3) age; and (4) sex. Because
we were interested in studying effects of secondary
degeneration of the hippocampus, we only included
participants with chronic stroke (defined as data acquired at least 180 days poststroke26). Behavioral data
were collected within ≈72 hours of the MRI. Exclusion
criteria included site-reported bilateral, brainstem, or
cerebellar lesions; participants with no identifiable lesions; and participants with no sensorimotor impairment (FMA-
UE=66). In addition, each hippocampus
was visually inspected with lesion masks overlaid, and
any brains with hippocampal lesions were excluded.
The total initial sample size was N=357 (age: median=61 years, interquartile range=18, range=23–93;
FMA-
UE:
median=41,
interquartile
range=28,
range=0–65; 135 women and 222 men) (Table 1).

MRI Data Analysis
Hippodeep, an automated convolutional neural
network-based hippocampal segmentation algorithm,
was used to segment ipsilesional and contralesional
hippocampal volumes as well as estimated total head
size from the T1-weighted MRI scan.27 Hippodeep was
previously found to be the most robust out of the freely

available methods for segmenting the hippocampus
in people with stroke pathology.28 Hippocampal segmentations were visually inspected according to previously described protocols.23,28 Any segmentations that
were not properly segmented were marked as failed
and excluded from the analysis. This resulted in different sample sizes for the ipsilesional and contralesional
analyses. More information on demographics of samples after quality control can be found in Tables S1
and S2. We performed a supplemental analysis using
only participants with hippocampal segmentations that
passed quality control for both ipsilesional and contralesional hippocampi and confirmed that differences in
sample sizes did not significantly influence the results
(Tables S3 through S6). To account for differences in
head size, hippocampal volume was normalized for
head size by taking the ratio of hippocampal volume
to head size for each participant and multiplying it by
the average head size across the sample, as done in
previous studies of poststroke hippocampal volume.7,8

Manually Segmented Lesions
Lesions were manually segmented on the T1w MRI
by B.L., M.D., J.S., A.Z.P., and S.-L.L. according to an
updated version of the Anatomical Tracings of Lesions
After Stroke (ATLAS) protocol.29 Briefly, brain lesions
were identified, and masks were manually drawn on
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each individual brain in native space using ITK-Snap.30
Each lesion was checked for quality by at least 2 different tracers. An expert neuroradiologist (G.B.) was also
consulted to ensure lesion segmentation accuracy. The
ATLAS protocol for manually tracing stroke lesions has
been technically validated, with high inter-and intrarater
reliability. More details on the criteria used to manually
trace lesions, including links to the lesion-tracing protocol, can be found in Liew and colleagues.29 The sample
includes 81 participants with cortical lesions, 100 participants with subcortical lesions, and 176 participants
with mixed cortical and subcortical lesions. Although
all participants were listed by the providing research
sites as having unilateral lesions, additional secondary lesions were discovered in 100 participants during
manual tracing, which were likely silent, subclinical, and/
or prior strokes. Secondary lesions were found in both
hemispheres, the brainstem, and the cerebellum, and
ranged in size. For this article, we refer to the primary
lesioned hemisphere as the lesioned hemisphere noted
by the research site. We also performed follow-up analyses excluding participants with any identified secondary
lesions (Figure S1), which did not significantly impact results (Tables S7 and S8). Lesion probability maps were
generated by nonlinearly normalizing lesion masks and
registering them to the MNI-152 template (Figure 1).
Finally, lesion volume was calculated by summing
the voxels within each lesion mask. Lesion size was
also normalized for head size as previously described
for hippocampal volume in MRI Data Analysis Section.
Lesion size was then log transformed to normalize the
distribution of the data.

ENIGMA Stroke Hippocampal Volumes

Sensorimotor Damage
Sensorimotor damage was estimated by calculating the
percentage of lesion voxels that overlapped with the sensorimotor cortex, supplementary motor cortex, thalamus,
or the basal ganglia, as calculated using the open-source
software Pipeline for Analyzing Lesions after Stroke
(PALS31). Briefly, T1w images and their accompanying lesion masks were nonlinearly registered to the MNI-152
template. Regions of interest reflecting the sensorimotor cortex, supplementary motor cortex, thalamus, and
basal ganglia were identified using the Desikan-Killiany
Atlas.32 Sensorimotor cortex and supplementary motor
cortex were estimated using the pre-and postcentral
gyrus. The basal ganglia were estimated using the caudate, pallidum, putamen, and nucleus accumbens. The
number of lesioned voxels in the sensorimotor cortex,
supplementary motor cortex, thalamus, and basal ganglia was summed and divided by the sum of the size of
each sensorimotor region. This value was then multiplied
by 100 to create a percent of lesion overlap with sensorimotor regions, reflecting sensorimotor damage.

Statistical Analysis
Hippocampal Volume and Sensorimotor
Impairment
We first tested our primary hypothesis that more severe
poststroke sensorimotor impairment is correlated with
smaller ipsilesional but not contralesional hippocampal volumes by performing robust mixed-effects linear
regressions with hippocampal volume as the dependent variable (see Model 1). Sensorimotor impairment

Figure 1. Lesion density maps for primary lesions from participants with cohort-reported left
and right hemisphere lesions are overlaid on a coronal (left) and axial (right) slice of the Montreal
Neurological Institute (MNI) MNI-152 template.
Lesioned hemisphere refers to the primary lesion, as reported by the research cohort. The color bar refers
to the percentage of overlapping lesions across participants.
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was measured using the FMA-UE.33 Sex (coded as a
binary variable: women=0, men=1), age, and lesioned
hemisphere (coded as binary variable: left hemisphere
lesion=0.5, right hemisphere lesion=1.5) were included
in the model as fixed effects and cohort was included
in the model as a random effect (Model 1):

Hippocampus∼FMA − UE
+ Sex + Age + Lesioned hemisphere
+ random (Cohort)

(1)

Next, we tested our exploratory hypothesis that
sex may have a moderating effect on the relationship
between sensorimotor impairment and hippocampal
volume by including an FMA-UE×Sex interaction covariate as a fixed effect (Model 2):
Hippocampus ∼ FMA − UE
+ Sex + FMA − UE × Sex
(2)
+ Age + Lesioned hemisphere
+ random (Cohort)
Sex differences in sensorimotor impairment, lesion
size, and age were tested using an independent t test.
Finally, we tested our hypothesis that sensorimotor
impairment is independently associated with hippocampal volume regardless of lesion size by including
lesion size as a fixed covariate (Model 3):
Downloaded from http://ahajournals.org by on September 19, 2022

Table 2. Summary Statistics From Robust Mixed-
Effects Linear Regression to Test Associations Between
Ipsilesional Hippocampal Volume and Sensorimotor
Impairment and Contralesional Hippocampal Volume and
Sensorimotor Impairment When Including a Sensorimotor
Impairment and Sex Interaction
Hippocampus~FMA-UE×Sex+FMA-UE+sex+lesioned
hemisphere+age+random (cohort)

Hippocampus ∼ Lesion size + FMA − UE
+ Sex + FMA − UE × Sex
+ Age + Lesioned hemisphere
+ random(Cohort)

(3)

Associations Between Lesion Size and
Hippocampal Volume
To investigate associations between lesion size and
hippocampal volume, regardless of sensorimotor impairment, we performed a robust mixed-effects regression with ipsilesional and contralesional hippocampal
volume as dependent variables with lesion size, age,
sex, and lesioned hemisphere as fixed effects, and cohort as a random effect (Model 4):

Hippocampus ∼ Lesion size
+ Sex + Age + Lesioned hemisphere
+ random (Cohort)

(4)

Associations Between Sensorimotor
Damage and Hippocampal Volume
We investigated our hypothesis that greater
sensorimotor-specific lesion damage would be associated with smaller ipsilesional hippocampal volumes
with a robust mixed-effects regression with ipsilesional
hippocampal volume as the dependent variable and
Table 3. Summary Statistics From Robust Mixed-
Effects Linear Regression to Test Associations Between
Ipsilesional Hippocampal Volume and Sensorimotor
Impairment and Contralesional Hippocampal Volume and
Sensorimotor Impairment When Including Lesion Size as a
Covariate
Hippocampus~lesion size+FMA-UE×Sex+FMA-UE+sex+lesioned
hemisphere+age+random (cohort)
Covariates

β (CI)

SE

P value

0.26 (0.10 to 0.41)*

0.08*

0.001*
0.008*

2

Ipsilesional hippocampal volume (N=336; R =0.33)
Covariates

β (CI)

SE

P value

FMA-UE*

2

Ipsilesional hippocampal volume (N=336; R =0.30)

FMA-UE×sex*

−0.26 (−0.45 to −0.07)*

0.10*

FMA-UE*

0.31 (0.15 to 0.46)*

0.08*

<0.001*

Lesion size*

−0.19 (−0.29 to −0.09)*

0.05*

<0.001*

FMA-UE×sex*

−0.26 (−0.46 to −0.07)*

0.10*

0.009*

Sex*

−0.58 (−0.78 to −0.39)*

0.10*

<0.001*

Sex*

−0.53 (−0.73 to −0.33)*

0.10*

<0.001*

0.17 (−0.03 to 0.36)

0.10

0.09

Lesioned
hemisphere

0.17 (−0.03 to 0.37)

0.10

0.09

Lesioned
hemisphere
Age*

−0.36 (−0.46 to −0.26)*

0.05*

<0.001*

Age*

−0.32 (−0.42 to −0.22)*

0.05*

<0.001*

Contralesional hippocampal volume (N=349; R2=0.32)

Contralesional hippocampal volume (N=349; R2=0.32)
FMA-UE

0.15 (0.00 to 0.30)

0.08

0.05
0.006*

FMA-UE

0.16 (0.01 to 0.31)

0.08

0.04

FMA-UE×sex*

−0.27 (−0.46 to −0.08)*

0.10*

FMA-UE×sex*

−0.27 (−0.46 to −0.08)*

0.10*

0.006*

Lesion size

−0.03 (−0.13 to 0.07)

0.05

0.58

Sex*

−0.51 (−0.70 to −0.32)*

0.10*

<0.001*

Sex*

−0.52 (−0.71 to −0.33)*

0.10*

<0.001*

Lesioned
hemisphere*

−0.35 (−0.54 to −0.16)*

0.10*

<0.001*

Lesioned
hemisphere*

−0.35 (−0.54 to −0.16)*

0.10*

<0.001*

Age*

−0.41 (−0.51 to −0.32)*

0.05*

<0.001*

Age*

−0.42 (−0.52 to −0.32)*

0.05*

<0.001*

The full model as well as the sample size (N), conditional R2, β coefficient
(β) with 95% CI, SE, and uncorrected P value for all fixed-effect covariates
are reported. FMA-UE indicates Fugl-Meyer Assessment of Upper Extremity.
*Significant covariates.

The full model as well as the sample size (N), conditional R2, β coefficient
(β) with 95% CI, SE, and uncorrected P value for all fixed-effect covariates
are reported. FMA-UE indicates Fugl-Meyer Assessment of Upper Extremity.
*Significant covariates.
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percent of sensorimotor damage, age, sex, and lesioned hemisphere as fixed effects, and cohort as a
random effect (Model 5):
Hippocampus ∼ Sensorimotor damage
+ Sex + Age + Lesioned hemisphere
(5)
+ random (Cohort)
We also tested the hypothesis that sensorimotor
damage is independently associated with hippocampal volume regardless of lesion size by including lesion
size as a fixed covariate (Model 6):

ENIGMA Stroke Hippocampal Volumes

Hippocampus ∼ Sensorimotor damage
+ Lesion size + Sex + Age
+ Lesioned hemisphere
+ random (Cohort)

(6)

Statistical Tools
All statistical analyses were performed in R (version 4.0.233).
The Mahalanobis distance was used to detect multivariate outliers,34 which were then removed from the analyses (Data S1). All continuous measures were normalized
using the scale function in R and analyzed as z-scores to
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Figure 2. Effect sizes (standardized β values) for ipsilesional and contralesional hippocampi are mapped onto a template
for associations between hippocampal volumes and sensorimotor impairment (top left) and lesion size (bottom left), with
warmer colors representing stronger positive associations.
Trend lines (black line) are plotted for the association between ipsilesional hippocampal volume z-scores with Fugl-Meyer Assessment
of Upper Extremity (FMA-UE) z-scores (top right) and lesion size z-scores (bottom right). Scatterplot points are colored by research
cohort.
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calculate standardized β coefficients. All mixed-effects regressions were initially run as linear mixed-effects regressions (lmer function from nlme package). To ensure that
there was no redundancy in the included independent
variables, collinearity for variables in every model tested
was ruled out (variance inflation factor ≤2.5; Tables S9
and S10). Regression assumptions of linearity, normality
of the residuals, and homogeneity of the residual variance were tested by visually inspecting residuals versus
fits plots as well as qq-plots. After detecting influential
observations using Cook’s distance in each analysis,35
the analyses were repeated using robust mixed-effects
regression. Robust mixed-effects regression (rlmer from
the robustlmm package) avoids excluding data by reducing the weight of influential observations.36 We therefore
report the results of the robust mixed-effects regression.
For all analyses, β coefficients for the factor of interest and
CIs (β [CI]), SE), and uncorrected P values are reported.
For each analysis, a Bonferroni correction was applied
for 2 comparisons (ipsilesional, contralesional; corrected
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P<0.025). Effect sizes were mapped onto a template of
the hippocampus to visualize the results using ggseg.37

RESULTS
Hippocampal Volume and Sensorimotor
Impairment
Greater sensorimotor impairment was significantly associated with smaller ipsilesional (β=0.16, P=0.005,
R2=0.27) but not contralesional (β=0.003, P=0.96,
R2=0.29) hippocampal volume after adjusting for age,
sex, lesioned hemisphere, and cohort (Table S11). When
including FMA-
UE×Sex interaction as a covariate, we
observed a better model fit and an increase in effect size
for the association between sensorimotor impairment
and ipsilesional hippocampal volume (β=0.31, P<0.001,
R2=0.30; Table 2). Furthermore, FMA-UE remained independently associated with ipsilesional hippocampal
volume after including lesion size in the model (β=0.26,
P=0.001, R2=0.33; Table 3, Figure 2). This association

Downloaded from http://ahajournals.org by on September 19, 2022
Figure 3. Trend lines are plotted for the association between Fugl-Meyer Assessment of Upper Extremity (FMA-UE) z-
score (x-a xis) and hippocampal volumes z-score (y-a xis) for women (red) and men (blue) calculated from the FMA-UE×Sex
interactions.
Histograms for FMA-UE scores (bottom left), age (bottom middle), and lesion size (bottom right) are plotted by sex (women in red and
men in blue).
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remained significant when excluding participants with
secondary lesions (β=0.30, P=0.001, R2=0.35; Table S7).

Sex Effects on the Association Between
Hippocampal Volume and Sensorimotor
Impairment
A t test revealed no significant differences in FMA-UE
(t[260])=1.13, P=0.26) or age (t[249]=1.12, P=0.26) between women and men. Women did have significantly
larger lesions than men (t[277]=2.9, P=0.004) (Figure 3).
The FMA-UE×Sex interaction was a significant covariate for both ipsilesional (β=−0.26, P=0.009, R2=0.30)
and contralesional (β=−0.27, P=0.006, R2=0.32) hippocampal volumes (Figure 3, Table 2), even after accounting for lesion size (ipsilesional: β=−0.26, P=0.008,
R2=0.33; contralesional: β=−0.27, P=0.006, R2=0.32;
Table 3). In the ipsilesional hippocampus, women had
a positive slope (β=0.26) and men had a negative slope
close to 0 (β=−0.002). In the contralesional hippocampus, women had a positive slope (β=0.15) while men
had a negative slope (β=−0.12) (Figure 3). The FMA-
UE×Sex interaction remained significantly associated
with both ipsilesional (β=−0.31, P=0.008, R2=0.35) and
contralesional (β=−0.28, P=0.017, R2=0.32) hippocampal volumes, even when excluding participants with
secondary lesions (Table S7).
Downloaded from http://ahajournals.org by on September 19, 2022

Hippocampal Volume and Lesion Size
Larger lesion size was significantly associated with
smaller ipsilesional (β=−0.21, P<0.001, R2=0.33) but
not contralesional hippocampal volume (β=−0.03,
P=0.60, R2=0.30), after adjusting for age, sex, lesioned
hemisphere, and cohort (Table S12; Figure 2). Lesion
size remained significantly associated with smaller ipsilesional, but not contralesional, hippocampal volume,
even when excluding participants with secondary lesions (β=−0.18, P=0.003, R2=0.33; Table S8).

Hippocampal Volume and Sensorimotor
Damage
More sensorimotor damage was significantly associated with a smaller ipsilesional hippocampal volume
(β=−0.15, P=0.003, R2=0.30; Table S13). However, this
association did not remain significant after including
lesion size in the model (β=−0.03, P=0.66, R2=0.32;
Table S14).

DISCUSSION
In this study, associations between sensorimotor impairment, lesion size, sex, and hippocampal volume
were investigated in participants with chronic stroke
from 18 research cohorts in the ENIGMA Stroke
Recovery Working Group.23 Greater sensorimotor
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impairment and larger lesion sizes were both significantly associated with smaller ipsilesional hippocampal
volumes, and the association between sensorimotor
impairment and hippocampal volume was stronger in
women than in men.
To our knowledge, this is the first study to report
associations between hippocampal volume and sensorimotor impairment in patients with chronic stroke.
Greater sensorimotor impairment was independently
associated with smaller ipsilesional hippocampal volume, even after adjusting for lesion size. This suggests
that poststroke ipsilesional hippocampal integrity may
be related to sensorimotor impairment. SD might explain the sensitivity of stroke-related ipsilesional hippocampal atrophy, where damaging neurotoxic signals
from the core of the lesion propagate to adjacent gray
matter regions.6–8 The blockage of blood supply during
the acute phase of a stroke leads to an ionic imbalance that causes a buildup of extracellular glutamate,
triggering a self-propagating wave of cell depolarization throughout neighboring gray matter.38 The hippocampus is filled with tightly packed, easily excitable
glutamatergic neurons and a high density of N-methyl-
d-aspartate receptors,39 making it more susceptible to
damage from SD. Overexcitation of the hippocampal
glutamatergic network leads to hippocampal excitotoxicity, resulting in hippocampal neuron apoptosis, which
is thought to be reflected on a macroscale as reduced
hippocampal volume.8 The damaging effects of SD are
likely more prominent in the lesioned hemisphere because SD waves do not propagate easily through white
matter38; therefore, the waves cannot easily traverse
to the contralesional hippocampus. While a magnetic
resonance spectroscopy study reported evidence of
hippocampal neuronal loss in the contralesional hippocampus, it was less severe and not detectable
using volumetric MRI.8 SD still is not well understood;
therefore, contralesional hippocampal damage may
be caused by mild SD or might be attributed to other
forms of secondary degeneration such as diaschisis.5
The available evidence is insufficient to support SD
as the key cause of reduced ipsilesional hippocampal
volumes observed in this study, and there are several
other mechanisms that may explain stroke-related hippocampal damage such as chronic inflammation.40
However, these findings could provide future directions
for research investigating the mechanisms of stroke-
related hippocampal damage.
One question is whether the smaller hippocampal
volumes observed is reflective of general atrophy of regions across the entire ipsilesional hemisphere, or if it
is specific to the hippocampus. Although the current
work cannot directly address this, because Hippodeep
only provides measures of hippocampal volume and
total brain volume, recent work examined relationships between the volumes of 5 subcortical regions
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associated with sensorimotor processing (ie, thalamus,
caudate, putamen, pallidum, and nucleus accumbens)
in relation to sensorimotor impairment after stroke.4
In chronic stroke, only the ipsilesional putamen was
significantly associated with sensorimotor impairment
specifically, suggesting that volumes of distinct regions
are related with sensorimotor deficits. Thus, it is likely
that the hippocampal association is a true relationship
and not reflective of general ipsilesional atrophy.
We initially hypothesized that in addition to hippocampal damage incurred by SD, ipsilesional disruption
to sensorimotor circuits may cause secondary degeneration of the ipsilesional hippocampus, possibly as
a result of anatomical connectivity to damaged areas
(eg, through the thalamus,15 basal ganglia,12 sensorimotor cortex,14 or supplementary motor area16) via anterograde degeneration. While we found a significant
relationship between extent of sensorimotor damage
and ipsilesional hippocampal volume, this relationship
became insignificant once lesion size was added into
the model. This suggests that smaller hippocampal
volumes are likely not attributed to secondary degeneration derived from ipsilesional disruption to sensorimotor circuits specifically. Further structural and
functional connectivity research as well as longitudinal
investigations may provide a more complete picture
of the role of hippocampal damage in sensorimotor
circuitry.
Furthermore, because the hippocampus is an important limbic system structure, it is heavily involved in
learning, memory, and emotion.39 Poststroke cognitive
impairment, depression, and anxiety are all common
pervasive symptoms in stroke survivors that interfere
with rehabilitation and are associated with poor stroke
outcomes.41 Limbic system disruption caused by secondary poststroke hippocampal damage may cause
cognitive impairment or aggravate symptoms of depression and anxiety, which in turn, may interfere with
stroke sensorimotor rehabilitation efforts. Further functional and longitudinal research is necessary to understand the relationship between hippocampal damage
and sensorimotor circuits and how hippocampal volume loss may impact sensorimotor rehabilitation.
In an exploratory analysis, we found significant sex
differences in the association between FMA-UE and
bilateral hippocampal volume, where women showed
progressively greater sensorimotor impairment with
smaller hippocampal volumes compared with men.
This observation suggests that women with greater
sensorimotor impairment may also have more hippocampal damage or more pre-existing hippocampal atrophy compared with men. In addition, sex differences
observed in the association between sensorimotor
impairment and hippocampal volume did not appear
to be driven by age or severity of sensorimotor impairment. Although lesion size was significantly larger in
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women, the FMA-
UE×Sex interaction covariate was
independently associated with hippocampal volume,
even when accounting for lesion size. Overall, these
findings should be considered exploratory given the
unequal number of men and women in the sample.
Further research is needed to confirm these findings,
because our sample was unable to account for additional variables thought to influence the hippocampus
in a sex-dependent way such as estrogen levels,19 dementia,17 and depression.42 Additionally, the current
sample does not have information about race, which
is known to affect stroke risk factors, possibly in a sex-
dependent way.43 Furthermore, the extent to which sex
differences observed in stroke research are a result of
physiological differences between sexes versus different contextual factors such as treatment received by
women poststroke remains unclear.21 For example,
a recent meta-analysis showed that women are less
likely to receive thrombolytic treatment thought to improve stroke outcomes, compared with men.44 Further
research on sex differences in stroke is crucial to improve our understanding of the relationship between
hippocampal damage and sensorimotor impairment.
Lastly, we found that larger lesion sizes were significantly associated with smaller hippocampal volumes,
but only within the lesioned hemisphere, independent
of sensorimotor impairment. This finding is in line with
a previous study7 and may indicate that smaller hippocampal volumes observed in patients with stroke may
be specific to the amount of stroke-related damage
within the lesioned hemisphere beyond that which is
attributed to age-related atrophy39 or other stroke risk
factors such as hypertension45 or changes in estrogen19 that are typically observed bilaterally.

Limitations and Future Directions
This study only considered gross hippocampal volume.
However, the hippocampus is composed of structurally and functionally distinct subfields, each differentially vulnerable to disease.46 Structurally, reduced
neuron density has been observed in the cells of the
CA1 subfield of postmortem patients with stroke when
compared with controls,47 and larger white matter hyperintensity volume has been associated with a smaller
hippocampal-amygdala transition area.48 Functionally,
while the posterior extents of the hippocampus along
the long axis are thought to be more involved with memory and cognitive processing,49 the anterior extents
have been implicated in sensorimotor integration.39
Further research investigating sensorimotor impairment
and the hippocampus at a finer resolution, such as at
the level of hippocampal subfields49 or vertex-wise associations,50 may reveal more specific and robust relationships that can better inform the understanding of
the impact of hippocampal damage on recovery and
rehabilitation.
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One limitation of the Hippodeep software used in
this study is that it only generates measurements for
hippocampal volume and total head size and does not
provide information about other brain regions such as
cortical and subcortical volumes. Further research is
necessary to compare the strength of associations between sensorimotor impairment and volumes of other
cortical and subcortical regions in relation to associations with hippocampal volume.
In addition, although secondary lesions were
discovered while manually tracing lesion masks,
our findings did not change when participants with
secondary lesions were excluded. Additionally, our
preliminary results on lesion location only investigated sensorimotor region damage. As mentioned
previously, the hippocampus is a densely connected
region and further research is necessary to investigate the impact of lesion location on the association
between hippocampal volume and sensorimotor
impairment.
Given the focus on hippocampal volumes, another
limitation of this study is the lack of cognitive and depression data. While cognitive and depressive scores are
available for a small number of cohorts in the ENIGMA
Stroke Recovery database, the participants with available data have very limited information. In addition, many
of the participating ENIGMA Stroke Recovery research
cohorts used cognitive impairment as an exclusion criterion, which is a fairly common practice in sensorimotor
rehabilitation research,51 resulting in participants with no
or mild cognitive deficits. However, given the high prevalence of poststroke dementia,52 future prospective studies collecting both sensorimotor and cognitive behavioral
information across a range of impairment levels are necessary to improve our understanding of how poststroke
cognitive impairment may interfere with sensorimotor
rehabilitation.53
Finally, the current sample is cross-sectional and
cannot account for the extent of longitudinal hippocampal atrophy that may have occurred as a result
of stroke, mild cognitive impairment, pre-existing dementia, or normal aging. Additionally, without longitudinal data, we cannot investigate the directionality
of the association between sensorimotor impairment
and hippocampal volume. Our findings reflect a cross-
sectional association, which does not imply causality.
Future well-powered longitudinal research should examine causal relationships between these 2 factors.
This sample also does not contain data on type or
dose of rehabilitation treatment received, which could
also influence sensorimotor outcomes. However, the
current cross-sectional analysis serves as a first step
to examining the relationship between hippocampal
volumes, sensorimotor impairment, lesion volume, and
sex and can be used to guide future questions using a
longitudinal data set.
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CONCLUSIONS
Our findings demonstrate a novel association between
chronic poststroke sensorimotor impairment and hippocampal volume that may be modulated by sex. We
provide supporting evidence to existing literature that
reduced hippocampal volume is likely a consequence
of stroke-
related damage within the lesioned hemisphere. Overall, these findings provide unique insight
into the role that the hippocampus may play in poststroke sensorimotor impairment.
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Data S1.

Data demographics following removal of multivariate outliers and
segmentations that failed quality control

3 participants were identified as multivariate outliers using the Mahalanobis distance. These
participants were excluded from the analysis. Additionally, 18 participants were excluded from the
ipsilesional analysis (Table S1) and 5 participants were excluded from the contralesional analysis (Table
S2), due to hippocampal segmentations that failed quality control. More details regarding ENIGMA quality
control protocols can be found in Zavaliangos-Petropulu et al., 2020 and Liew et al., 2020. Briefly, a
segmentation failed quality control if the segmentation grossly underestimated the hippocampus,
Downloaded from http://ahajournals.org by on September 19, 2022

overestimated the hippocampus by including regions of the brain outside of the hippocampus, or missed
the hippocampus entirely. To ensure that differing sample sizes for the ipsilesional and contralesional
analyses did not influence the results, we performed a supplemental analysis only including participants
with hippocampal segmentations that passed quality control for both ipsilesional and contralesional
hippocampi (Tables S3-S6).

Table S1. Detailed demographics for the sample used to analyze sensorimotor impairment and
ipsilesional hippocampal volume.
Women

Men
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Cohort

N

Age (yrs)

FMA-UE

Lesion Size (cc)

N

Age (yrs)

FMA-UE

Lesion Size (cc)

Cohort 1

10

53 (14,31-75)

35 (16,0-58)

8.1 (31.5,1.1-96.6)

26

65 (12,42-80)

44 (13,19-56)

3.8 (7.6,0-37)

Cohort 2

3

64 (17,51-85)

31 (17,14-48)

9.8 (24.6,6.3-55.5)

5

71 (18,39-74)

37 (22,13-46)

10 (23.4,4.2-34.1)

Cohort 3

6

62 (9,35-85)

15 (7,5-18)

21.6 (16.1,1.3-112.4)

6

52 (15,33-71)

29 (11,5-40)

7.6 (6.7,0.6-113.4)

Cohort 4

5

34 (19,30-68)

11 (5,9-34)

48.8 (23.4,9.7-90)

10

46 (11,32-63)

9 (11,1-24)

31.9 (30,8.1-130.2)

Cohort 5

12

62.5 (14,44-81)

55 (21,22-65)

1.7 (6.2,0.1-70.2)

16

67 (18,50-81)

40 (32,8-65)

5.2 (66.6,0.3-237.7)

Cohort 6

3

63 (10, 2-72)

65 (0,65-65)

5 (4.3,0.5-9.1)

7

59 (14,49-66)

64 (9,45-65)

1.3 (0.5,0.6-2.2)

Cohort 7

5

61 (4,57-65)

49 (43,14-63)

4.3 (1.3,0.3-6.9)

9

53 (10,45-69)

63 (4,6-65)

1.5 (1.2,0.04-5.3)

Cohort 8

4

58 (16,45-74)

50 (10,32-55)

45.2 (43,0.7-64.6)

7

56 (9,45-68)

45 (15,25-55)

35.8 (47.2,0.9-103.9)

Cohort 9

3

59 (1, 8-60)

42 (11,26-49)

2.5 (11.6,0.8-24)

8

59 (5,45-68)

36 (20,15-49)

4.9 (22,0.7-53.7)

Cohort 10

4

61 (11,46-73)

55 (9,35-58)

10.9 (28,0.4-59)

3

58 (4,56-64)

43 (11,37-59)

37 (27.3,1.4-55.9)

Cohort 11

6

65 (5,51-75)

47 (24,23-61)

5.2 (31.3,0.4-201.4)

16

59 (10,23-75)

49 (18,29-64)

5.8 (42,0.6-71)

Cohort 12

4

51 (16,32-62)

58 (8,54-63)

1.8 (14.5,0.3-55.9)

9

58 (7,47-80)

48 (11,38-62)

8.2 (17.8,1.3-98)

Cohort 13

4

68 (20,31-75)

60 (4,51-62)

23.2 (55,0.5-107.5)

7

68 (19,52-83)

37 (31,19-61)

4.5 (30.3,0.2-62.6)

Cohort 14

17

50 (15,36-79)

41 (15,24-47)

13.6 (44.7,0.7-143.6)

11

50 (15,25-76)

44 (9,31-53)

3.8 (12.5,0.1-32.4)

Cohort 15

3

47 (11,42-63)

18 (5,11-21)

36.7 (91.4,3.2-186.1)

7

62 (12,51-76)

35 (16,23-60)

8.6 (3.3,3-97.5)

Cohort 16

14

68 (12,43-93)

48 (33,20-65)

12.1 (24.9,1.1-54.4)

26

65 (9,45-81)

47 (26,4-62)

8 (25.2,0.5-111.8)

Cohort 17

15

68 (19,37-79)

38 (34,8-64)

7.6 (31.2,0.5-188.4)

20

72 (12,51-80)

56 (11,23-65)

5.2 (22,0.3-110.8)

Cohort 18

12

62 (15,34-85)

28 (5,14-34)

15.6 (47.9,0.8-136.9)

13

65 (17,50-78)

27 (4,23-33)

3.1 (3.6,0.7-34.1)

Total

130

60 (20,30-93)

39 (29,0-65)

9.3 (39.5,0.11-201.4)

206

62 (16,23-83)

44 (25,1-65)

5.6 (24.1,0.04-237.7)

Demographics for women and men are broken down by cohort. Sample size (N) and median (IQR, range)
of age, FMA-UE, and raw lesion size are reported.

Table S2. Detailed demographics for the sample used to analyze sensorimotor impairment and
contralesional hippocampal volume.
Women

Men
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Cohort

N

Age (yrs)

FMA-UE

Lesion Size (cc)

N

Age (yrs)

FMA-UE

Lesion Size (cc)

Cohort 1

10

53 (14,31-75)

35 (16,0-58)

8.1 (31.5,1.1-96.6)

28

64 (17,32-80)

44 (13,19-56)

4.9 (12,0.04-120.8)

Cohort 2

6

66 (9,51-85)

23 (29,13-48)

38 (39,6.3-137.4)

6

71 (14,39-74)

36 (17,13-46)

19 (26.2,4.2-34.1)

Cohort 3

6

62 (9,35-85)

15 (7,5-18)

21.6 (16.1,1.3-112.4)

8

57 (17,33-71)

22 (22,5-40)

10.5 (50.6,0.6-171.2)

Cohort 4

5

34 (19,30-68)

11 (5,9-34)

48.8 (23.4,9.7-90)

12

45 (11,32-63)

8 (11,1-24)

31.9 (38.8,4.5-130.2)

Cohort 5

12

63 (14,44-81)

55 (21,22-65)

1.7 (6.2,0.1-70.2)

16

67 (18,50-81)

40 (32,8-65)

5.2 (66.6,0.3-237.7)

Cohort 6

3

63 (10,52-72)

65 (0,65-65)

5 (4.3,0.5-9.1)

7

59 (14,49-66)

64 (9,45-65)

1.3 (0.5,0.6-2.2)

Cohort 7

5

61 (4,57-65)

49 (43,14-63)

4.3 (1.3,0.3-6.9)

9

53 (10,45-69)

63 (4,6-65)

1.5 (1.2,0.04-5.3)

Cohort 8

4

58 (16,45-74)

50 (10,32-55)

45.2 (43,0.7-64.6)

7

56 (9,45-68)

45 (15,25-55)

35.8 (47.2,0.9-103.9)

Cohort 9

3

59 (1,58-60)

42 (11,26-49)

2.5 (11.6,0.8-24)

8

59 (5,45-68)

36 (20,15-49)

4.9 (22,0.7-53.7)

Cohort 10

4

61 (11,46-73)

55 (9,35-58)

10.9 (28,0.4-59)

4

57 (4,53-64)

43 (5,37-59)

39.2 (16.9,1.4-55.9)

Cohort 11

6

65 (5,51-75)

47 (24,23-61)

5.2 (31.3,0.4-201.4)

16

59 (10,23-75)

49 (18,29-64)

5.8 (42,0.6-71)

Cohort 12

4

51 (16,32-62)

58 (8,54-63)

1.8 (14.5,0.3-55.9)

8

58 (9,47-80)

51 (11,43-62)

6.5 (9,1.3-34.3)

Cohort 13

4

68 (20,31-75)

60 (4,51-62)

23.2 (55,0.5-107.5)

8

66 (16,52-83)

40 (27,19-61)

3.4 (27,0.2-62.6)

Cohort 14

18

49 (14,36-79)

41 (15,24-47)

14.3 (45.9,0.7-143.6)

10

54 (15,25-76)

43 (9,31-53)

3.1 (10.8,0.1-16.5)

Cohort 15

3

47 (11,42-63)

18 (5,11-21)

36.7 (91.4,3.2-186.1)

7

62 (12,51-76)

35 (16,23-60)

8.6 (3.3,3-97.5)

Cohort 16

14

68 (12,43-93)

48 (33,20-65)

12.1 (24.9,1.1-54.4)

26

65 (9,45-81)

47 (26,4-62)

8 (25.2,0.5-111.8)

Cohort 17

15

68 (19,37-79)

38 (34,8-64)

7.6 (31.2,0.5-188.4)

20

72 (12,51-80)

56 (11,23-65)

5.2 (22,0.3-110.8)

Cohort 18

12

62 (15,34-85)

28 (5,14-34)

15.6 (47.9,0.8-136.9)

15

64 (14,50-78)

27 (4,19-34)

4.8 (18.8,0.7-100.4)

Total

134

61 (20,30-93)

39 (29,0-65)

9.7(42.1,0.1-201.4)

215

62 (16,23-83)

43 (26,1-65)

5.8 (26.9,0.04-237.7)

Demographics for women, men, and total are broken down by cohort. Sample size (N) and median (IQR,
range) of age, FMA-UE, and raw lesion size are reported.

Table S3. Summary statistics from robust mixed-effects linear regression to test associations between
ipsilesional hippocampal volume and sensorimotor impairment (top) and contralesional hippocampal
volume and sensorimotor impairment (bottom) in participants who passed quality control for
bilateral hippocampi.
Hippocampus ~ FMA-UE + Sex + Lesioned Hemisphere + Age + random(Cohort)
Covariates

Beta(CI)

SE

p-value

IPSILESIONAL HIPPOCAMPAL VOLUME (N=334; R2=0.27)
FMA-UE

0.16 (0.05 – 0.27)

0.06

0.004

Sex

-0.54 (-0.74 – -0.34)

0.10

<0.001

Lesioned Hemisphere

0.19 (-0.01 – 0.39)

0.10

0.06

Age

-0.32 (-0.43 – -0.22)

0.05

<0.001

CONTRALESIONAL HIPPOCAMPAL VOLUME (N=334; R2=0.33)
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FMA-UE

0.02 (-0.09 – 0.12)

0.05

0.78

Sex

-0.55 (-0.75 – -0.36)

0.10

<0.001

Lesioned Hemisphere

-0.36 (-0.56 – -0.16)

0.10

0.001

Age

-0.41 (-0.51 – 0.32)

0.05

<0.001

The full model as well as the sample size (N), conditional R2, beta coefficient (Beta) with 95% confidence
interval (CI), standard error (SE), and uncorrected p-value for all fixed effect covariates are reported.
Significant covariates are denoted in bold.

Table S4. Summary statistics from robust mixed-effects linear regression to test associations between
ipsilesional hippocampal volume and sensorimotor impairment (top) and contralesional hippocampal
volume and sensorimotor impairment (bottom) when including a sensorimotor impairment and sex
interaction in participants who passed quality control for bilateral hippocampi.
Hippocampus ~ FMA-UE*Sex + FMA-UE + Sex + Lesioned Hemisphere + Age + random(Cohort)
Covariates

Beta(CI)

SE

p-value

IPSILESIONAL HIPPOCAMPAL VOLUME (N=334; R2=0.29)
FMA-UE

0.32 (0.16 – 0.47)

0.08

<0.001

FMA-UE*Sex

-0.27 (-0.47 – -0.07)

0.10

0.007

Sex

-0.54 (-0.74 – -0.35)

0.10

<0.001

Lesioned Hemisphere

0.18 (-0.03 – 0.38)

0.10

0.09

Age

-0.32 (-0.43 – -0.22)

0.05

<0.001

CONTRALESIONAL HIPPOCAMPAL VOLUME (N=334; R2=0.35)
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FMA-UE

0.17 (0.02 – 0.32)

0.08

0.028

FMA-UE*Sex

-0.27 (-0.46 – -0.08)

0.10

0.006

Sex

-0.56 (-0.76 – -0.37)

0.10

<0.001

Lesioned Hemisphere

-0.38 (-0.58 – -0.19)

0.10

<0.001

Age

-0.42 (-0.51 – -0.32)

0.05

<0.001

The full model as well as the sample size (N), conditional R2, beta coefficient (Beta) with 95% confidence
interval (CI), and uncorrected p-value for all fixed effect covariates are reported. Significant covariates are
denoted in bold.

Table S5. Summary statistics from robust mixed-effects linear regression to test associations between
ipsilesional hippocampal volume and sensorimotor impairment (top) and contralesional hippocampal
volume and sensorimotor impairment (bottom) when including lesion size as a covariate in
participants who passed quality control for bilateral hippocampi.
Hippocampus ~ Lesion Size + FMA-UE*Sex + FMA-UE + Sex + Lesioned Hemisphere + Age + random(Cohort)
Covariates

Beta(CI)

SE

p-value

IPSILESIONAL HIPPOCAMPAL VOLUME (N=334; R2=0.32)
FMA-UE

0.27 (0.11 – 0.42)

0.08

0.001

FMA-UE*Sex

-0.27 (-0.46 – -0.08)

0.10

0.006

Lesion Size

-0.19 (-0.30 – -0.09)

0.05

<0.001

Sex

-0.60 (-0.79 – -0.40)

0.10

<0.001

Lesioned Hemisphere

0.17 (-0.03 – 0.37)

0.10

0.09

Age

-0.36 (-0.46 – -0.26)

0.05

<0.001
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CONTRALESIONAL HIPPOCAMPAL VOLUME (N=334; R2=0.34)
FMA-UE

0.17 (0.01 – 0.32)

0.08

0.032

FMA-UE*Sex

-0.27 (-0.46 – -0.08)

0.10

0.006

Lesion Size

-0.01 (-0.11 – 0.09)

0.05

0.84

Sex

-0.57 (-0.76 - -0.37)

0.10

<0.001

Lesioned Hemisphere

-0.38 (-0.52 – -0.32)

0.10

<0.001

Age

-0.42 (-0.52 – -0.32)

0.05

<0.001

The full model as well as the sample size (N), conditional R2, beta coefficient (Beta) with 95% confidence
interval (CI), standard error (SE), and uncorrected p-value for all fixed effect covariates are reported.
Significant covariates are denoted in bold.

Table S6. Summary statistics from robust mixed-effects linear regression to test associations between
ipsilesional hippocampal volume and lesion size (top) and contralesional hippocampal volume and
lesion size (bottom) in participants who passed quality control for bilateral hippocampi.
Hippocampus ~ Lesion Size + Sex + Lesioned Hemisphere + Age + random(Cohort)
Covariates

Beta(CI)

SE

p-value

IPSILESIONAL HIPPOCAMPAL VOLUME (N=334; R2=0.32)
Lesion Size

-0.22 (-0.32 – -0.12)

0.05

<0.001

Sex

-0.59 (-0.79 – -0.39)

0.10

<0.001

Lesioned Hemisphere

0.17 (-0.03 – 0.36)

0.10

0.10

Age

-0.35 (-0.45 – -0.25)

0.05

<0.001

CONTRALESIONAL HIPPOCAMPAL VOLUME (N=334; R2=0.33)

Downloaded from http://ahajournals.org by on September 19, 2022

Lesion Size

-0.01 (-0.11 – 0.09)

0.05

0.81

Sex

-0.56 (-0.75 – -0.36)

0.10

<0.001

Lesioned Hemisphere

-0.36 (-0.56 – -0.17)

0.10

0.001

Age

-0.42 (-0.52 – -0.32)

0.05

<0.001

The full model as well as the sample size (N), conditional R2, beta coefficient (Beta) with 95% confidence
interval (CI), standard error (SE), and uncorrected p-value for all fixed effect covariates are reported.
Significant covariates are denoted in bold.

Table S7. Summary statistics from robust mixed-effects linear regression to test associations between
ipsilesional hippocampal volume and sensorimotor impairment (top) and contralesional hippocampal
volume and sensorimotor impairment (bottom) when including lesion size as a covariate and
excluding participants with secondary lesions.
Hippocampus ~ Lesion Size + FMA-UE*Sex + Lesioned Hemisphere + Age + random(Cohort)
Covariates

Beta(CI)

SE

p-value

IPSILESIONAL HIPPOCAMPAL VOLUME (N=240; R2=0.35)
FMA-UE

0.30 (0.12 – 0.48)

0.09

0.001

FMA-UE*Sex

-0.31 (-0.53 – -0.08)

0.11

0.008

Lesion Size

-0.14 (-0.27 – -0.02)

0.06

0.019

Sex

-0.57 (-0.80 – -0.35)

0.11

<0.001

Lesioned Hemisphere

0.18 (-0.06 – 0.41)

0.12

0.14

Age

-0.29 (-0.41 – -0.18)

0.06

<0.001
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CONTRALESIONAL HIPPOCAMPAL VOLUME (N=245 R2=0.32)
FMA-UE

0.18 (0.00 – 0.35)

0.09

0.05

FMA-UE*Sex

-0.28 (-0.50 – -0.05)

0.12

0.017

Lesion Size

0.05 (-0.08 – 0.17)

0.06

0.45

Sex

-0.45 (-0.68 – -0.22)

0.12

<0.001

Lesioned Hemisphere

-0.38 (-0.62 – -0.15)

0.12

0.001

Age

-0.36 (-0.48 – -0.25)

0.06

<0.001

The full model as well as the sample size (N), conditional R2, beta coefficient (Beta) with 95% confidence
interval (CI), standard error (SE), and uncorrected p-value for all fixed effect covariates are reported.
Significant covariates are denoted in bold.

Table S8. Summary statistics from robust mixed-effects linear regression to test associations between
ipsilesional hippocampal volume and lesion size (top) and contralesional hippocampal volume and
lesion size (bottom) after excluding participants with secondary lesions.
Hippocampus ~ Lesion Size + Sex + Lesioned Hemisphere + Age + random(Cohort)
Covariates

Beta(CI)

SE

p-value

IPSILESIONAL HIPPOCAMPAL VOLUME (N=240; R2=0.33)
Lesion Size

-0.18 (-0.30 – -0.06)

0.06

0.003

Sex

-0.58 (-0.80 – -0.35)

0.12

<0.001

Lesioned Hemisphere

0.16 (-0.08 – 0.39)

0.12

0.19

Age

-0.28 (-0.40 – -0.16)

0.06

<0.001

CONTRALESIONAL HIPPOCAMPAL VOLUME (N=245; R2=0.29)
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Lesion Size

0.04 (-0.08 – 0.16)

0.06

0.53

Sex

-0.45 (-0.68 – -0.22)

0.12

<0.001

Lesioned Hemisphere

-0.37 (-0.60 – -0.14)

0.12

0.002

Age

-0.36 (-0.48 – -0.24)

0.06

<0.001

The full model as well as the sample size (N), conditional R2, beta coefficient (Beta) with 95% confidence
interval (CI), standard error (SE), and uncorrected p-value for all fixed effect covariates are reported.
Significant covariates are denoted in bold.

Table S9. To ensure no redundancy in the included independent variables, collinearity for variables
in every model tested was ruled out (variance inflation factor ≤ 2.5).
Model 1

Model 2

Model 3

Covariates

VIF

Covariates

VIF

Covariates

VIF

FMA-UE

1.0

FMA-UE

2.1

Lesion Size

1.1

Sex

1.0

Sex

1.0

FMA-UE

2.1

Age

1.0

FMA-UE*Sex

2.1

Sex

1.0

Lesioned Hemisphere

1.0

Age

1.0

FMA-UE*Sex

2.1

Lesioned Hemisphere

1.0

Age

1.1

Lesioned Hemisphere

1.0

Model 4

Model 5

Model 6
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Covariates

VIF

Covariates

VIF

Covariates

VIF

Lesion Size

1.1

Sensorimotor Damage

1.1

Lesion Size

1.7

Sex

1.0

Sex

1.0

Sensorimotor Damage

1.7

Age

1.0

Age

1.1

Sex

1.0

Lesioned Hemisphere

1.0

Lesioned Hemisphere

1.0

Age

1.1

Lesioned Hemisphere

1.0

Variance inflation factors (VIF) for each variable in every model testing associations with ipsilesional
hippocampal volume is listed.

Table S10. To ensure no redundancy in the included independent variables, variance inflation factors
(VIF) for each variable in every model testing associations with contralesional hippocampal volume
is listed.
Model 1

Model 2

Model 3

Covariates

VIF

Covariates

VIF

Covariates

VIF

FMA-UE

1.0

FMA-UE

2.2

Lesion Size

1.0

Sex

1.0

Sex

1.0

FMA-UE

2.3

Age

1.0

FMA-UE*Sex

2.2

Sex

1.0

Lesioned Hemisphere

1.0

Age

1.0

FMA-UE*Sex

2.2

Lesioned Hemisphere

1.0

Age

1.1

Lesioned Hemisphere

1.0

Model 4
Covariates

VIF

Lesion Size

1.0

Sex

1.0

Age

1.0

Lesioned Hemisphere

1.0
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Table S11. Summary statistics from robust mixed-effects linear regression to test associations
between ipsilesional hippocampal volume and sensorimotor impairment (top) and contralesional
hippocampal volume and sensorimotor impairment (bottom).
Hippocampal Volume ~ FMA-UE + Sex + Lesioned Hemisphere + Age + random(Cohort)
Covariates

Beta(CI)

SE

p-value

IPSILESIONAL HIPPOCAMPAL VOLUME (N=336; R2=0.27)
FMA-UE

0.16 (0.05 – 0.27)

0.06

0.005

Sex

-0.53 (-0.73 – -0.33)

0.10

<0.001

Lesioned Hemisphere

0.19 (-0.01 – 0.39)

0.10

0.06

Age

-0.32 (-0.42 – -0.22)

0.05

<0.001

CONTRALESIONAL HIPPOCAMPAL VOLUME (N=349; R2=0.29)
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FMA-UE

0.003 (-0.10 – 0.11)

0.05

0.96

Sex

-0.50 (-0.69 – -0.31)

0.10

<0.001

Lesioned Hemisphere

-0.32 (-0.51 – -0.13)

0.10

0.001

Age

-0.41 (-0.51 – 0.32)

0.05

<0.001

The full model as well as the sample size (N), conditional R2, beta coefficient (Beta) with 95% confidence
interval (CI), standard error (SE), and uncorrected p-value for all fixed effect covariates are reported.
Significant covariates are denoted in bold.

Table S12. Summary statistics from robust mixed-effects linear regression to test associations
between ipsilesional hippocampal volume and lesion size (top) and contralesional hippocampal
volume and lesion size (bottom).
Hippocampal Volume ~ Lesion Size + Sex + Lesioned Hemisphere + Age + random(Cohort)
Covariates

Beta(CI)

SE

p-value

IPSILESIONAL HIPPOCAMPAL VOLUME (N=336; R2=0.33)
Lesion Size

-0.21 (-0.31 – -0.12)

0.05

<0.001

Sex

-0.58 (-0.77 – -0.38)

0.10

<0.001

Lesioned Hemisphere

0.16 (-0.03 – 0.36)

0.10

0.10

Age

-0.35 (-0.45 – -0.25)

0.05

<0.001

CONTRALESIONAL HIPPOCAMPAL VOLUME (N=349; R2=0.30)
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Lesion Size

-0.03 (-0.12 – 0.07)

0.05

0.60

Sex

-0.51 (-0.70 – -0.32)

0.10

<0.001

Lesioned Hemisphere

-0.32 (-0.51 – -0.13)

0.10

0.001

Age

-0.42 (-0.52 – -0.32)

0.05

<0.001

The full model as well as the sample size (N), conditional R2, beta coefficient (Beta) with 95% confidence
interval (CI), standard error (SE), and uncorrected p-value for all fixed effect covariates are reported.
Significant covariates are denoted in bold.

Table S13. Summary statistics from robust mixed-effects linear regression to test associations
between ipsilesional hippocampal volume and sensorimotor damage.
Hippocampal Volume ~ Sensorimotor Damage + Sex + Lesioned Hemisphere + Age + random(Cohort)
Covariates

Beta(CI)

SE

p-value

IPSILESIONAL HIPPOCAMPAL VOLUME (N=334; R2=0.30)
Sensorimotor Damage

-0.15 (-0.25 – -0.05)

0.05

0.003

Sex

-0.56 (-0.76 – -0.36)

0.10

<0.001

Lesioned Hemisphere

0.17 (-0.03 – 0.37)

0.10

0.10

Age

-0.34 (-0.45 – -0.24)

0.05

<0.001

Two participants were removed from the analysis due to poor image registration. The full model as well as
the sample size (N), conditional R2, beta coefficient (Beta) with 95% confidence interval (CI), standard
error (SE), and uncorrected p-value for all fixed effect covariates are reported. Significant covariates are
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denoted in bold.

Table S14. Summary statistics from robust mixed-effects linear regression to test associations
between ipsilesional hippocampal volume and sensorimotor damage after accounting for lesion size.
Hippocampal Volume ~ Sensorimotor Damage + Lesion Size + Sex + Lesioned Hemisphere + Age + random(Cohort)
Covariates

Beta(CI)

SE

p-value

IPSILESIONAL HIPPOCAMPAL VOLUME (N=334; R2=0.30)
Sensorimotor Damage

-0.03 (-0.15 – -0.10)

0.06

0.66

Lesion Size

-0.20 (-0.32 – -0.38)

0.06

0.002

Sex

-0.58 (-0.78 – -0.38)

0.10

<0.001

Lesioned Hemisphere

0.16 (-0.03 – 0.36)

0.10

0.10

Age

-0.35 (-0.46 – -0.25)

0.05

<0.001

Two participants were removed from the analysis due to poor image registration. The full model as well as
the sample size (N), conditional R2, beta coefficient (Beta) with 95% confidence interval (CI), standard
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error (SE), and uncorrected p-value for all fixed effect covariates are reported. Significant covariates are
denoted in bold.

Figure S1. Lesion density maps for lesions from participants with cohort-reported left and right
hemisphere lesions, and without any secondary lesions (e.g., bilateral, brainstem or cerebellar
lesions), overlaid on the Montreal Neurological Institute (MNI) MNI-152 template.
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